Search Results - "Scudder, S"

Prospective Evaluation of Cancer Clinical Trial Accrual Patterns: Identifying Potential Barriers to Enrollment by Lara, Jr, P N, Higdon, R, Lim, N, Kwan, K, Tanaka, M, Lau, D H, Wun, T, Welborn, J, Meyers, F J, Christensen, S, O'Donnell, R, Richman, C, Scudder, S A, Tuscano, J, Gandara, D R, Lam, K S

“…Well-conducted cancer clinical trials are essential for improving patient outcomes. Unfortunately, only 3% of new cancer patients participate in clinical…”
Get full text

Stage III Endometrial Cancer Treated With Consolidative Pelvic Radiation: The Impact of Additional Dose With Vaginal Brachytherapy by Huddleston, A.J, Zhen, S, Qi, L, Rash, D.L, Scudder, S, Leiserowitz, G, Mayadev, J.S

Get full text

AMG 386 combined with either pegylated liposomal doxorubicin or topotecan in patients with advanced ovarian cancer: Results from a phase Ib study by Wenham, R, Schilder, R, Pippitt, C, Wong, S, Ananda, S, Scudder, S, Melara, R, Nanayakkara, N, Adewoye, H, Vergote, I

Get full text

Chemoradiation for primary invasive squamous carcinoma of the vagina by Dalrymple, J L, Russell, A H, Lee, S W, Scudder, S A, Leiserowitz, G S, Kinney, W K, Smith, L H

“…To report outcomes for patients with primary, invasive, squamous carcinoma of the vagina treated with chemoradiation. Between 1986 and 1996, 14 patients were…”
Get more information

Evidence of Sea Level Rise at the Early Ostionan Coralie Site (GT-3), c. AD 700, Grand Turk, Turks and Caicos Islands by Scudder, Sylvia

“…Soil and sediment analyses were conducted on samples from the early Ostionan Coralie Site (c.ad705±60) on Grand Turk, Turks and Caicos Islands, the earliest…”
Get full text

Primary clear cell adenocarcinoma of the rectovaginal septum treated with concurrent chemoradiation therapy: a case report by Guiou, M, Hall, W H, Konia, T, Scudder, S, Leiserowitz, G, Ryu, J K

“…Primary clear cell adenocarcinoma of the rectovaginal septum is rare and typically emerges in the setting of endometriosis. We report a case of a 52-year-old…”
Get more information

Endometriosis-related malignancies by Leiserowitz, G S, Gumbs, J L, Oi, R, Dalrymple, J L, Smith, L H, Ryu, J, Scudder, S, Russell, A H

“…The purpose of this study is to describe the clinical findings, treatment, and outcome of patients with endometriosis-related cancers. Patients meeting Sampson…”
Get more information

Phase II trial of carboplatin and infusional cyclosporine with alpha-interferon in recurrent ovarian cancer: a California Cancer Consortium Trial by Morgan, Jr, R J, Synold, T W, Gandara, D, Muggia, F, Scudder, S, Reed, E, Margolin, K, Raschko, J, Leong, L, Shibata, S, Tetef, M, Vasilev, S, McGonigle, K, Longmate, J, Yen, Y, Chow, W, Somlo, G, Carroll, M, Doroshow, J H

“…The purpose of this study was to estimate the response rate of 26-h continuous infusion cyclosporine A (CSA) combined with carboplatin (CBDCA) and subcutaneous…”
Get more information

Prophylactic Chemoradiation of Inguinofemoral Lymph Nodes in Patients with Locally Extensive Vulvar Cancer by Leiserowitz, Gary S., Russell, Anthony H., Kinney, Walter K., Smith, Lloyd H., Taylor, Michael H., Scudder, Sidney A.

“…Objective.Primary surgical resection of locally advanced squamous cancer of the vulva may compromise the integrity of important midline structures such as the…”
Get full text

Clinicopathologic significance of transitional cell carcinoma pattern in nonlocalized ovarian epithelial tumors (stages 2-4) by COSTA, M. J, HANSEN, C, DICKERMAN, A, SCUDDER, S. A

“…The transitional cell carcinoma (TCC) pattern has been associated with favorable outcome in patients with late-stage ovarian epithelial tumors who receive…”
Get full text

Tirapazamine plus cisplatin in advanced or recurrent carcinoma of the uterine cervix: a Southwest Oncology Group study by Smith, H O, Jiang, C S, Weiss, G R, Hallum, 3rd, A V, Liu, P Y, Robinson, 3rd, W R, Cheng, P C, Scudder, S A, Markman, M, Alberts, D S

“…The objective of this study was to determine objective response and overall survival (OS) and progression-free survival (PFS) following cisplatin plus…”
Get more information

13-cis-Retinoic Acid or All-trans-Retinoic Acid plus Interferon-α in Recurrent Cervical Cancer: A Southwest Oncology Group Phase II Randomized Trial by Weiss, Geoffrey R., Liu, P.Y., Alberts, David S., Peng, Yei-Mei, Fisher, Emily, Xu, Min Jian, Scudder, Sidney A., Baker, Laurence H., Moore, Dennis F., Lippman, Scott M.

“…Purpose.Preclinical and clinical data support the study of retinoids and interferon-α (IFN-α) in advanced squamous cell carcinoma of the uterine cervix (SCC)…”
Get full text

1560PDisease monitoring of EGFR mutation-positive NSCLC patients via circulating tumour DNA by Hsu, W F, Ho, H-L, Chiang, C L, Jiang, Y, Karwowska, S M, Yerram, R, Sharma, K, Sharma, A, Scudder, S, Tsai, C-M, Palma, J, Chiu, C-H, Chou, T-Y

“…Abstract Background 15–40% of NSCLC patients harbor EGFR sensitizing mutations. Tyrosine kinase inhibitors (TKI) provide significant clinical benefit in this…”
Get full text

1560P - Disease monitoring of EGFR mutation-positive NSCLC patients via circulating tumour DNA by Hsu, W.F., Ho, H.-L., Chiang, C.L., Jiang, Y., Karwowska, S.M., Yerram, R., Sharma, K., Sharma, A., Scudder, S., Tsai, C.-M., Palma, J., Chiu, C.-H., Chou, T.-Y.

“…15–40% of NSCLC patients harbor EGFR sensitizing mutations. Tyrosine kinase inhibitors (TKI) provide significant clinical benefit in this population, yet all…”
Get full text

Disease monitoring of EGFR mutation-positive NSCLC patients via circulating tumour DNA by Hsu, W.F., Ho, H.-L., Chiang, C.L., Jiang, Y., Karwowska, S.M., Yerram, R., Sharma, K., Sharma, A., Scudder, S., Tsai, C.-M., Palma, J., Chiu, C.-H., Chou, T.-Y.

Get full text

1416PEnhanced access to EGFR molecular testing in NSCLC using a cell-free DNA tube for liquid biopsy by May, T E, Scudder, S A, Joshi, S J, Kohlmann, M, Shrestha, N, Lee, N, Højbjerg, J A, Lai, J, Madsen, A T, Clement, M S, Meldgaard, P, Tsourounis, M, Sørensen, B, Kohlmann, A, O’Donnell, P, Halait, H

“…Abstract Background The clinical utility of non-invasive liquid biopsy and ability to accurately detect EGFR mutations in circulating-tumor DNA of patients…”
Get full text

Red, redder, reddest: SCUBA-2 imaging of colour-selected Herschel sources by Duivenvoorden, S, Oliver, S, Scudder, J M, Greenslade, J, Riechers, D A, Wilkins, S M, Buat, V, Chapman, S C, Clements, D L, Cooray, A, Coppin, K E K, Dannerbauer, H, De Zotti, G, Dunlop, J S, Eales, S A, Efstathiou, A, Farrah, D, Geach, J E, Holland, W S, Hurley, P D, Ivison, R J, Marchetti, L, Petitpas, G, Sargent, M T, Scott, D, Symeonidis, M, Vaccari, M, Vieira, J D, Wang, L, Wardlow, J, Zemcov, M

“…Abstract High-redshift, luminous, dusty star-forming galaxies (DSFGs) constrain the extremity of galaxy formation theories. The most extreme are discovered…”
Get full text

A phase I study including pharmacokinetics of polyethylene glycol conjugated interleukin-2 by Meyers, F J, Paradise, C, Scudder, S A, Goodman, G, Konrad, M

“…A more soluble formulation of recombinant interleukin-2 with a prolonged half-life would allow alternate routes or schedules of administration and enhance…”
Get more information

Urinary gonadotropin peptide (UGP) as a marker of gynecologic malignancies by Walker, R, Crebbin, V, Stern, J, Scudder, S, Schwartz, P

“…Urinary gonadotropin peptide (UGP) was measured in 866 urines from normal women and women with benign and malignant gynecologic disease using the Triton UGP…”
Get more information

Immunohistochemical markers of cell cycle control applied to ovarian and primary peritoneal surface epithelial neoplasms: p21 [formula omitted] predicts survival and good response to platinin-based chemotherapy by Costa, Michael J, Hansen, Christian L, Walls, Judy E, Scudder, Sidney A

“…Immunohistochemistry for p53, p21 WAF1 CIP1 , and Ki-67 provides insight into the molecular events controlling the cell cycle. We tested the hypothesis that…”
Get full text